0001127602-23-025798.txt : 20231012
0001127602-23-025798.hdr.sgml : 20231012
20231012160118
ACCESSION NUMBER: 0001127602-23-025798
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231010
FILED AS OF DATE: 20231012
DATE AS OF CHANGE: 20231012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEBBANE RAYMOND
CENTRAL INDEX KEY: 0001053890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 231322726
MAIL ADDRESS:
STREET 1: C/O THE INVUS GROUP, LLC
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-10-10
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001053890
DEBBANE RAYMOND
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
THE WOODLANDS
TX
77381
1
0
Common Stock
5451204
I
By Invus US Partners LLC
Common Stock
2023-10-10
4
P
0
508306
1.1398
A
849153
D
Common Stock
2023-10-11
4
P
0
342874
1.0814
A
1192027
D
Common Stock
2023-10-12
4
P
0
148820
1.0335
A
1340847
D
This transaction was executed in multiple trades at prices ranging from $1.09 to $1.19 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
This transaction was executed in multiple trades at prices ranging from $1.06 to $1.12 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $1.02 to $1.07 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
/s/ Raymond Debbane
2023-10-12